Literature DB >> 3951697

Multiple sclerosis in the Faroe Islands. II. Clinical update, transmission, and the nature of MS.

J F Kurtzke, K Hyllested.   

Abstract

In this century, 41 Faroese with MS were ascertained. One subset, after living in Denmark for 2 years between ages 11 and 31, had MS onset an average of 6 years later. In the Faroes, MS occurred as three separate and decreasing epidemics beginning in 1943 and ending in 1973. We believe that asymptomatic British troops introduced the first epidemic during 1941 to 1942, with the later epidemics resulting from transmission by affected but asymptomatic Faroese. We conclude that "MS" is a widespread, systemic, specific infectious disease only rarely causing neurologic symptoms and transmissible at most from ages 13 to 26.

Entities:  

Mesh:

Year:  1986        PMID: 3951697     DOI: 10.1212/wnl.36.3.307

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  17 in total

1.  Age dependence of clinical and pathological manifestations of autoimmune demyelination. Implications for multiple sclerosis.

Authors:  M E Smith; N L Eller; H F McFarland; M K Racke; C S Raine
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

2.  IgG subclass responses to Theiler's murine encephalomyelitis virus infection and immunization suggest a dominant role for Th1 cells in susceptible mouse strains.

Authors:  J D Peterson; C Waltenbaugh; S D Miller
Journal:  Immunology       Date:  1992-04       Impact factor: 7.397

3.  Risk factors for multiple sclerosis: race or place?

Authors:  A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-10       Impact factor: 10.154

Review 4.  Genetic epidemiology of multiple sclerosis.

Authors:  A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-06       Impact factor: 10.154

Review 5.  Epidemiologic evidence for multiple sclerosis as an infection.

Authors:  J F Kurtzke
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

6.  Human coronavirus gene expression in the brains of multiple sclerosis patients.

Authors:  J N Stewart; S Mounir; P J Talbot
Journal:  Virology       Date:  1992-11       Impact factor: 3.616

7.  Multiple sclerosis: genetic versus environmental aetiology: epidemiology in Israel updated.

Authors:  E Kahana; N Zilber; J H Abramson; V Biton; Y Leibowitz; O Abramsky
Journal:  J Neurol       Date:  1994-03       Impact factor: 4.849

8.  High incidence and prevalence of multiple sclerosis in south east Scotland: evidence of a genetic predisposition.

Authors:  P M Rothwell; D Charlton
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-06       Impact factor: 10.154

9.  Effectiveness of amantadine in reducing relapses in multiple sclerosis.

Authors:  G S Plaut
Journal:  J R Soc Med       Date:  1987-02       Impact factor: 18.000

10.  Isolation of Clostridium perfringens type B in an individual at first clinical presentation of multiple sclerosis provides clues for environmental triggers of the disease.

Authors:  Kareem Rashid Rumah; Jennifer Linden; Vincent A Fischetti; Timothy Vartanian
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.